Latest News
Drug Trial
Merck Serono S.A. - Geneva is developing an experimental drug and is currently recruiting SLE patients into a phase II/ III study globally, with 5 research sites across the UK (Manchester Royal Infirmary, University College London Hospitals - London, Whipps Cross University Hospital - London, Royal Hallamshire Hospital - Sheffield, Freeman Hospital - Newcastle).This study is intended to evaluate how effective this experimental drug is compared to placebo in preventing new flares. For further information please visit:
http://www.clinicaltrials.gov/ct2/show/NCT00624338?cond=%22Systemic+Lupus+Erythematosus%2C+SLE%22&rank=1
If you are interested in participating please discuss this with your Rheumatologist taking this information along with you. Merck Serono has provided a donation to LUPUS UK as a thanks for allowing Merck Serono to display this information.
Systemic Lupus Erythematosus and the Mouth
Sjogren's Syndrome - Systemic Features
Lupus in Children and Young People
Training the new generation doctors
Drug Therapy of Lupus
Gastrointestinal Manifestations of SLE
BBC Pilot
Downing Street Reception for LUPUS UK
19th Annual Conference and AGM
New advances in the treatment of Lupus and the Antiphospholipid (Hughes) Syndrome
Read more: New advances in the treatment of Lupus and the Antiphospholipid (Hughes) Syndrome
Can we communicate better with our Doctors? (and importantly, they with us!)
Read more: Can we communicate better with our Doctors? (and importantly, they with us!)
More Articles...
- The Benefits and Risks of Treatment Regimes for SLE Cocktails or Dogs Breakfast?
- Lupus & Diet
- Lupus in Childhood
- Making the Difference
- An Overview on Lupus Medication
- New Therapies for Systemic Lupus
- Fatigue in Lupus
- LUPUS - Diagnosis, Treatment, the Future
- SLE Then and Now
- Your Lupus Dictionary A - Z
